Lagoda Investment Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-38,930
| Closed | -$1.06M | – | 40 |
|
|
2023
Q3 | $1.06M | Sell |
38,930
-18,250
| -32% | -$495K | 0.69% | 19 |
|
|
2023
Q2 | $1.76M | Sell |
57,180
-44,320
| -44% | -$1.36M | 1.24% | 17 |
|
|
2023
Q1 | $3.66M | Sell |
101,500
-17,580
| -15% | -$633K | 2.6% | 16 |
|
|
2022
Q4 | $4.71M | Sell |
119,080
-22,225
| -16% | -$878K | 3.18% | 14 |
|
|
2022
Q3 | $5.68M | Buy |
141,305
+4,670
| +3% | +$188K | 4.04% | 13 |
|
|
2022
Q2 | $5.74M | Sell |
136,635
-4,925
| -3% | -$207K | 3.81% | 13 |
|
|
2022
Q1 | $5.52M | Buy |
141,560
+1,125
| +0.8% | +$43.8K | 2.97% | 14 |
|
|
2021
Q4 | $5.6M | Buy |
140,435
+18,950
| +16% | +$755K | 2.65% | 16 |
|
|
2021
Q3 | $4.39M | Buy |
121,485
+11,680
| +11% | +$422K | 2.19% | 17 |
|
|
2021
Q2 | $4.5M | Buy |
109,805
+4,970
| +5% | +$204K | 2.1% | 17 |
|
|
2021
Q1 | $4.57M | Buy |
104,835
+7,950
| +8% | +$347K | 2.28% | 16 |
|
|
2020
Q4 | $4.85M | Buy |
96,885
+44,648
| +85% | +$2.23M | 2.61% | 16 |
|
|
2020
Q3 | $2.2M | Buy |
+52,237
| New | +$2.2M | 1.63% | 16 |
|